AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Company seeks new drug indication for treatment of heart attack survivors.

Medical Letter on the CDC & FDA

| January 25, 2004 | COPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 JAN 25 - (NewsRx.com & NewsRx.net) -- Novartis Pharmaceuticals Corporation announced it has filed a supplemental new drug application with the U.S. Food and Drug Administration (FDA) seeking approval for a new indication for Diovan (valsartan) to improve survival and reduce cardiovascular events in patients at high risk after surviving a heart attack.

The new filing is based on the positive results of VALIANT (Valsartan in Acute Myocardial Infarction Trial), the largest long-term study ever conducted in post-heart attack patients which investigated 14,703 people.

VALIANT demonstrated that Diovan prolongs survival after heart attack as effectively as the

Related articles from newspapers, magazines, journals, and more
Diovan[R] receives approval in Sweden to treat high-risk heart attack patients.
News wire article from: Europe Intelligence Wire December 1, 2004 700+ words
...risk following a recent heart attack. Diovan is the first drug in its...countries, have approved Diovan to treat post-heart attack patients. Heart attack...at high risk following a heart attack. Diovan is the only cardiovascular...
LANDMARK DIOVAN TRIAL PROVES BENEFITS FOR HEART ATTACK SUFFERERS.
News wire article from: AsiaPulse News November 11, 2003 700+ words
...Patients Following a Heart Attack VALIANT Further...Strengthens the Profile of Diovan in Cardiovascular...have survived a heart attack. This critical...helps establish Diovan as a highly desirable...Medical Center. Diovan reduces risk for premature death after heart ...
Novartis Files sNDA for its Leading High Blood Pressure Drug Diovan(R) to...
Press release article from: PR Newswire December 22, 2003 700+ words
...new indication for Diovan(R) (valsartan...after surviving a heart attack. The new filing...conducted in post-heart attack patients which investigated...demonstrated that Diovan prolongs survival after heart attack as effectively as...
Novartis files sNDA for its leading high blood pressure drug Diovan to improve...
News wire article from: Asia Africa Intelligence Wire December 22, 2003 700+ words
...new indication for Diovan (valsartan) to...after surviving a heart attack. The new filing...conducted in post-heart attack patients which investigated...demonstrated that Diovan prolongs survival after heart attack as effectively as...
Diovan receives approval in Sweden to treat high-risk heart attack patients.
Newspaper article from: Cardiovascular Week December 27, 2004 700+ words
...following a recent heart attack. Diovan is the first drug...international trial proving Diovan to be as effective...preventing death of heart attack survivors as a current...have approved Diovan to treat post-heart-attack patients. This...
Diovan[R] receives EU approval for the treatment of heart attack survivors.
News wire article from: Europe Intelligence Wire May 9, 2005 700+ words
...for the treatment of heart attack survivors. Diovan, a proven, powerful...heart attack. The post-heart attack indication for Diovan is based on the positive...high risk following a heart attack. Diovan is the only cardiovascular...
New data demonstrate benefits of Diovan in reducing life-threatening...
News wire article from: Europe Intelligence Wire September 5, 2005 700+ words
...have had a recent heart attack or people with heart failure. Diovan is the only ARB with...risk following a heart attack. VALIANT also showed that Diovan is well-tolerated...who have survived a heart attack. Diovan megatrials A new...
Study: Diovan is also potentially a life-saving treatment after heart attack.
Magazine article from: Women's Health Weekly December 11, 2003 700+ words
...have survived a heart attack. VALIANT demonstrated that Diovan has all the established...patients following a heart attack. VALIANT adds...cumulative evidence for Diovan in cardiovascular...risk following a heart attack." Diovan could potentially...
Leading High Blood Pressure Drug Diovan(R) (valsartan) Is Also Potentially A...
Press release article from: PR Newswire November 10, 2003 700+ words
...have survived a heart attack. VALIANT demonstrated that Diovan has all the established...treating high-risk heart attack survivors...already rely on Diovan for highly effective...risk following a heart attack." Diovan could potentially...
Multimedia News Release - Leading High Blood Pressure Drug Diovan(R)...
Press release article from: PR Newswire November 11, 2003 700+ words
...patients following a heart attack. VALIANT adds...cumulative evidence for Diovan in cardiovascular...treating high-risk heart attack survivors...already rely on Diovan for highly effective...risk following a heart attack." Diovan could potentially...
For more facts and information, see all results

Source: HighBeam Research, Company seeks new drug indication for treatment of heart attack...

©2010 Gale, a part of Cengage Learning. All rights reserved. About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily